pharmaguideline vulnerabilities and fixes
Recent CVEs affecting pharmaguideline, with upgrade or downgrade steps. 1 tracked.
pharmaguideline has 1 tracked vulnerability, 0 critical. A fixed release or vendor patch exists for 0. Most recent: 2014-09-26. Highest priority: CVE-2014-6721 (score 32/100).
- CVE-2014-6721 MEDIUM 5.4 DOWNGRADE The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates
FAQ
How do I fix pharmaguideline vulnerabilities?
Open the CVE for your version, check the affected range, then follow the listed action: upgrade to the fixed release, or downgrade or mitigate if no fix exists yet. Commands for each OS are shown on every CVE page.
Is pharmaguideline being exploited right now?
None of the tracked pharmaguideline CVEs are on the CISA Known Exploited Vulnerabilities list at the moment. This is checked every 20 minutes.
Which pharmaguideline CVE should I patch first?
CVE-2014-6721 currently ranks highest (32/100): The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates.